Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Retained Earnings: 2021

Historic Retained Earnings for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to -$66.6 million.

  • Cardiol Therapeutics' Retained Earnings fell 33.59% to -$82.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$82.0 million, marking a year-over-year decrease of 33.59%. This contributed to the annual value of -$66.6 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Cardiol Therapeutics reported Retained Earnings of -$66.6 million as of FY2021.
  • In the past 5 years, Cardiol Therapeutics' Retained Earnings ranged from a high of -$66.6 million in FY2021 and a low of -$66.6 million during FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Retained Earnings value was -$66.6 million (recorded in 2021), while the average stood at -$66.6 million.